Juan Carlos Ramı́rezGonzalo R. AcevedoCarolina TorresRudy ParradoAnabelle de la BarraSandro VillarroelLineth GarcíaJoaquím GascónLourdes OrtizFaustino Torrico2026-03-222026-03-22202110.1093/jac/dkab446https://doi.org/10.1093/jac/dkab446https://andeanlibrary.org/handle/123456789/50865Citaciones: 5Genetic variability of T. cruzi bloodstream populations during post-treatment follow-up did not differ from that observed during chronic infection in the absence of treatment, suggesting that there were no selection events of E1224-resistant parasite populations. This is the first report documenting the genetic polymorphism of natural T. cruzi populations in chronic patients in the context of clinical trials with trypanocidal drugs.enMinicircleBiologyChagas diseaseTrypanosoma cruziKinetoplastGenetic variationGeneticsXenodiagnosisImmunologyarticle